»search site
The International Academy of Cardiology is dedicated to Cardiology Online - International Academy of Cardiologythe advancement of global research in cardiovascular medicine through the support of scientific meetings and publications.
   Home Page
   Congresses
   Journals
   Organizations
   Institutions
   Books
   Research
   Guidelines
   Discussion Groups
   Webcourses
   Websites
   Job Opportunities
   Contact Us




 

 

 

 


21st World Congress on Heart Disease

 

DOES CYSTATIN SN INFLUENCE ON CYSTATIN C LEVEL IN ISCHEMIA AND PREVIOUS MYOCARDIAL INFARCTION?



Tatiana A. Korolenko, Ph.D., Institute Physiol. Fund. Med., Novosibirsk, Russia

 

Objectives: To investigate whether patients with ischemic heart disease and previous myocardial infarction (MI) display altered serum cystatin C/cystatin SN ratio.

Background: Cystatin C, the extracellular inhibitor of cysteine proteases with protective role in vascular remodeling, was recently suggested as a candidate biomarker in CV pathology, but cystatin SN belonging to cystatin C1 superfamily, can neutralize the cystatin C inhibition of cathepsin B in circulating fluids.

Methods: 34 male patients (61.8 7.3 years) with MI, treated by statins, were enrolled in a study from the Outpatient Clinic N 1 of Novosibirsk. The control group consisted of 25 healthy persons (50-65 years old). Serum CRP-hs, Cystatin C (immunoturbidimetric method), Cystatin SN (CST1) by ELISA kits (Cusabio, China) were assayed.

Results: In persons, aged 50-65, an elevation in serum cystatin SN (3.900.45 versus control 2.43 0.20 ng/ml, p<0.001) and increased cystatin C (1.11 0.23 mg/L, p< 0.01) was shown versus healthy persons, aged 20-40 years. Statin treatment in patients with ischemia and previous MI normalized dyslipidemia, however increased CRP-hs (p<0.001) as well as increased cystatin C level C (2.05 0.21 mg/L, p < 0.001) vs the control (aged 50-65) were still noted, but serum cystatin SN level decreased.

Conclusions: Decreased cystatin SN level in patients with ischemia and MI can influence on inhibition in cystatin C/cathepsin B, followed by changes in cystatin C concentration in circulating blood.

 

 

©1998-2017 Cardiology Online, Inc. All rights reserved.
Cardiology Online is a registered trademark of Cardiology Online, Inc.
CardiologyOnline.com